is tirzepatide a pill or injection for medical weight loss and diabetes management Both deliver the same medication,

"WELCOME10" for discount 10% on your first order

Huo, Samantha et al

1 Dual agonism of GIP and GLP-1 receptors is a promising new approach currently in clinical development for the treatment of diabetes, obesity, and associated complications [1] The incretin effect defines the main physiological role of GIP and GLP-1 GIP and GLP-1 increase insulin secretion following nutrient-induced secretion from the gut (incretin effect): There is a stronger insulin secretion response to oral compared to 'isoglycemic' intravenous glucose administration due to secretion and action of incretin hormones

You can find additional explanations in the later sections of the article that will enhance your understanding

For topical hair research applications, the peptide can be reconstituted and incorporated into topical formulations aqueous solutions, serums, or spray vehicles designed for scalp application